← FDA DRUG APPROVALS
FDA ANDA · ANDA218405
SITAGLIPTIN AND METFORMIN HYDROCHLORIDE
Sponsor: MANKIND PHARMA LTD
APPLICATION
ANDA218405
TYPE
ANDA
DOSAGE FORM
TABLET
MARKETING STATUS
None (Tentative Approval)
Products
SITAGLIPTIN AND METFORMIN HYDROCHLORIDENone (Tentative Approval)
SITAGLIPTIN, METFORMIN HYDROCHLORIDE 50MG · TABLET
SITAGLIPTIN AND METFORMIN HYDROCHLORIDENone (Tentative Approval)
SITAGLIPTIN, METFORMIN HYDROCHLORIDE 500MG · TABLET
Approval history
2026-05-21UNKNOWN · Original · standardTA
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.